1995
DOI: 10.1016/0378-1119(94)00652-9
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic relevance of aberrations in the erbB oncogenes from breast, ovarian, oral and lung cancers: Double-differential polymerase chain reaction (ddPCR) for clinical diagnosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

5
13
0

Year Published

1998
1998
2016
2016

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 35 publications
(18 citation statements)
references
References 15 publications
5
13
0
Order By: Relevance
“…60% of tumours harboured p53 mutations, which agrees with previous reports 14,39 . 95% of mutations in p53 occur within highly conserved regions (exons [5][6][7][8]. The present study showed a higher frequency of mutations in exons 7 and 8 (60%) than in 5 and 6, which is in line with data published by CHAVES et al 8 .…”
supporting
confidence: 95%
“…60% of tumours harboured p53 mutations, which agrees with previous reports 14,39 . 95% of mutations in p53 occur within highly conserved regions (exons [5][6][7][8]. The present study showed a higher frequency of mutations in exons 7 and 8 (60%) than in 5 and 6, which is in line with data published by CHAVES et al 8 .…”
supporting
confidence: 95%
“…[35][36][37][38] These receptors cooperate in promoting cell growth and in inhibiting the differentiation of breast cancer cell lines; 37,38 increased copy number of the erb B1-B2-B3 genes positively correlates with lymph node metastasis in breast, oral, and ovarian cancer. 35 Moreover, overexpression of all members of the type I receptor family was detected in papillary carcinoma of the thyroid, in comparison with its normal counterpart. 36 Nevertheless, the role of such growth factor receptors as prognostic parameters in patients with common human malignancies has not been fully explored.…”
Section: Discussionmentioning
confidence: 99%
“…Reports of one group showed an increased copy number of the HER2 gene (17q11) in oral cavity HNSCC (Brandt et al, 1995;Werkmeister et al, 1996;2000). In addition, several studies have demonstrated increased HER2/ERBB2 oncoprotein levels (Werkmeister et al, 1996;Ibrahim et al, 1999;Xia et al, 1999).…”
Section: Discussionmentioning
confidence: 99%